Long-Term Extension Study With Eptinezumab as Preventive Treatment in Participants With Migraine in Japan
Clinical trial NCT05064371 · COMPLETED
Trial details
- NCT number
- NCT05064371
- Sponsor
- H. Lundbeck A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-21
- Primary completion
- 2024-06-08
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.